Saltar al contenido
Merck

Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy.

Science (New York, N.Y.) (2020-08-21)
François Binet, Gael Cagnone, Sergio Crespo-Garcia, Masayuki Hata, Mathieu Neault, Agnieszka Dejda, Ariel M Wilson, Manuel Buscarlet, Gaelle Tagne Mawambo, Joel P Howard, Roberto Diaz-Marin, Celia Parinot, Vera Guber, Frédérique Pilon, Rachel Juneau, Rémi Laflamme, Christina Sawchyn, Karine Boulay, Severine Leclerc, Afnan Abu-Thuraia, Jean-François Côté, Gregor Andelfinger, Flavio A Rezende, Florian Sennlaub, Jean-Sébastien Joyal, Frédérick A Mallette, Przemyslaw Sapieha
RESUMEN

In developed countries, the leading causes of blindness such as diabetic retinopathy are characterized by disorganized vasculature that can become fibrotic. Although many such pathological vessels often naturally regress and spare sight-threatening complications, the underlying mechanisms remain unknown. Here, we used orthogonal approaches in human patients with proliferative diabetic retinopathy and a mouse model of ischemic retinopathies to identify an unconventional role for neutrophils in vascular remodeling during late-stage sterile inflammation. Senescent vasculature released a secretome that attracted neutrophils and triggered the production of neutrophil extracellular traps (NETs). NETs ultimately cleared diseased endothelial cells and remodeled unhealthy vessels. Genetic or pharmacological inhibition of NETosis prevented the regression of senescent vessels and prolonged disease. Thus, clearance of senescent retinal blood vessels leads to reparative vascular remodeling.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
SB265610, ≥98% (HPLC)